EE Impact

Pugang Pharmaceutical Corporation

North Korea · Pharma & Healthcare

LeaveRussia detail: Continue Operations

Still operating in Russia

Korea Pugang Corporation (Korean: 조선부강회사) is a North Korean holding company founded in 1979. Pugang Pharmaceutic Company (Korean: 부강제약회사; 富强製藥會社) is a pharmaceutical company founded in 1983. It is operated by North Korea's Ministry of Public Health. Although the company had its assets frozen as a result of U.S. sanctions, its products are sold internationally by Lekar Korea, a distributor based in Russia.

Status last verified 03/08/2026Source checked 17/11/2025Company website ↗LeaveRussia profile ↗

Business in Russia

North Korea plans to sell its drugs in Russia, which treat everything from insomnia to leukemia. Of course, their effectiveness hasn't been proven.

Decision trail

Decision date 27/05/2025 · Reference ↗

Krasnodar company "Gradient" imports to Russia the injectable dietary supplement "Kumdan-2", produced by North Korean Pugang Pharmaceutical Corporation, according to data from the Federal Accreditation Service. The DPRK authorities advertise this product as a universal cure for all diseases - MERS, SARS and even HIV/AIDS.

Status history since 2022

  1. 03/08/2026 operating · Imported from KSE LeaveRussia

Exposure profile

Full exposure profile is a Professional feature

Energy, transport and commodity exposure, supplier/customer links in the region and sanctioned-party proximity.

Upgrade to Professional
Statuses, logos and narrative notes are compiled from public reporting and the KSE LeaveRussia project. Found an error? See our corrections policy.